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Background: Stem cell-based therapy has recently been explored for the treatment of disorders of the enteric
nervous system (ENS). Pluripotent embryonic stem (ES) cells represent an attractive cell source; however, little or no
information is currently available on how ES cells will respond to the gut environment. In this study, we
investigated the ability of ES cells to respond to environmental cues derived from the ENS and related tissues, both
in vitro and in vivo.
Methods: Neurospheres were generated from mouse ES cells (ES-NS) and co-cultured with organotypic
preparations of gut tissue consisting of the longitudinal muscle layers with the adherent myenteric plexus (LM-MP).
Results: LM-MP co-culture led to a significant increase in the expression of pan-neuronal markers (βIII-tubulin, PGP
9.5) as well as more specialized markers (peripherin, nNOS) in ES-NS, both at the transcriptional and protein level.
The increased expression was not associated with increased proliferation, thus confirming a true neurogenic effect.
LM-MP preparations exerted also a myogenic effect on ES-NS, although to a lesser extent. After transplantation
in vivo into the mouse pylorus, grafted ES-NS failed to acquire a distinct phenotype al least 1 week following
transplantation.
Conclusions: This is the first study reporting that the gut explants can induce neuronal differentiation of ES cells
in vitro and induce the expression of nNOS, a key molecule in gastrointestinal motility regulation. The inability of
ES-NS to adopt a neuronal phenotype after transplantation in the gastrointestinal tract is suggestive of the
presence of local inhibitory influences that prevent ES-NS differentiation in vivo.
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Several enteric neuronal disorders, such as achalasia,
Hirschprung disease, congenital pyloric stenosis and
pseudo-obstruction, are characterized by the loss or mal-
function of critical neuronal subpopulations of the enteric
nervous system (ENS) [1,2]. These conditions result in a
severe impairment of digestive functions, for which current
surgical and pharmacological therapeutic approaches are
not very satisfactory, with the exception of pyloromyotomy
for pyloric stenosis [3]. Novel approaches for the treatment
of enteric neuropathies are therefore needed and in this* Correspondence: ppasric1@jhmi.edu
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reproduction in any medium, provided the orrespect, stem cell-based replacement of dead or malfunc-
tioning enteric neurons is a promising therapeutic tool
[4,5].
Multipotent neural stem cells (NSC) isolated from the
brain of embryonic mice can be transplanted in the gut of a
transgenic model of gastroparesis and promote significant
functional recovery as early as 1 week post-grafting [6-8].
However, the therapeutic use of CNS-derived NSC is lim-
ited by the scarce availability of donor tissue and the poor
ability of multipotent NSC to generate large number of cells
for transplantation in vitro. Recent evidence has also shown
that enteric neuronal progenitor cells (ENPC) can be
derived by autologous biopsy and can be grafted in organo-
typic gut preparations in vitro [9]. Nevertheless thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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after ENPC grafting need further investigation.
Embryonic stem (ES) cells can theoretically overcome
many of these limitations and represent an alternative
approach to neural precursors. ES cells are pluripotent
cells derived from the inner cell mass of pre-
implantation blastocysts [10]. ES cells can be propagated
almost indefinitely in culture as undifferentiated cells
but, under appropriate conditions, are capable of differ-
entiating both in vitro and in vivo into a variety of cell
types including neural cells [11,12]. Over the years,
several protocols have been developed to efficiently de-
rive specialized neural cell types such as dopaminergic
[13-15], serotonergic [16], GABAergic and glutamatergic
[17], telencephalic [18], cerebellar [19], motor [20] neu-
rons from ES cells. Experimental approaches include ag-
gregation into embryoid bodies followed by treatment
with retinoic acid (RA), selective propagation of ES
aggregates in defined media supplemented with growth
factors, culture of ES cells on a monolayer or condi-
tioned media of bone marrow-derived stromal cells
(PA6) and genetic lineage selection [21,22]. Furthermore,
several studies have also shown ES differentiation into
neural crest cells, the developmental progenitors of the
ENS, by using combination of defined factors in culture
[23–26]. From a therapeutic perspective, therefore, it is
of great interest to know whether gut environmental sig-
nals can instruct ES cells to differentiate into locally ap-
propriate neuronal types and whether these signals can
be further analyzed to improve post-grafting success. Ac-
cordingly, the aim of this study was to investigate the
effects of putative differentiating cues derived from the
ENS and associated gut tissue on ES cells both in vitro
and in vivo.
Methods
All experimental animal protocols were approved by the
Institutional Animal Care and Use Committee at the
University of Texas Medical Branch (Galveston, Texas)
in accordance with the guidelines provided by the Na-
tional Institute of Health.
Mouse ES cells culture
Mouse ES cells from 129/Ola strain (a kind gift of Dr. Jie
Du) were maintained for no more than 25 passages in
feeder-free conditions on gelatin coated flasks (bovine gel-
atin from Sigma-Aldrich, flasks from Nunc), in Glasgow’s
modified Eagle’s medium (Sigma-Aldrich, St. Louis, MO)
supplemented with 2 mM L-glutamine (Invitrogen Corp.,
Carlsbad, CA), 1 mM sodium pyruvate and 1X solution of
non-essential amino acids (both from Sigma-Aldrich, St.
Louis, MO), 10% fetal bovine serum (FBS; HyClone),
50 μM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO),
100 μg/ml Primocin antibiotic (Amaxa Inc.) and 1000 U/mlLIF (ESGRO, Millipore). ES cells were sub-cultured using
0.05% trypsin/0.02% EDTA (Invitrogen Corp., Carlsbad,
CA) in phosphate buffered saline (PBS) and plated at
25,000-30,000 cells cm-2 in freshly gelatinized flasks.
Alkaline phosphatase assay was carried out using the
Alkaline Phosphatase Detection Kit (Millipore) accord-
ing to manufacturer’s instructions.
Induction of neurospheres from mouse ES cells
ES cells were trypsinized and plated at a density of
30,000 cells cm-2 onto non-coated flasks in neurobasal
medium containing 2 mM L-glutamine, B27 supplement
and 100 U/ml penicillin-streptomycin (NB27 medium;
all reagents from Invitrogen Corp.), plus 1000 U/ml LIF,
10 ng/ml FGF2 and 50 ng/ml EGF (Promega). Cells were
cultured for 7 days as floating multicellular aggregates
termed ES-derived neurospheres or ES-NS.
Isolation and in vitro culture of mouse CNS-derived neural
stem cells (CNS-NSC)
Cell culture reagents were obtained from Invitrogen Co.
(Carlsbad, California) except where noted. Staged-pregnant
female GFP mice (TgN(GFPU)5Nagy, Jackson Laboratory,
Bar Harbor, Maine) at embryonic day 15 (E15) were
anesthetized with sodium pentobarbital (70 mg/kg, i.p.) and
a midline incision was made to expose the embryos. The
brains of embryonic mice were removed and the subventri-
cular zone (SVZ) dissected from each brain hemisphere.
The tissues were washed in Ca2+- and Mg2+ -free Hank’s
Buffered Salt Solution (HBSS) and digested using a combin-
ation of dispase type I (0.1%) and trypsin (0.005%) for 10
minutes at 37°C. After digestion, a cell suspension was
obtained by gentle trituration, pelleted and resuspended in
Neurobasal medium containing B27, 2 mM glutamine and
penicillin-streptomycin (NB27), plus 20 ng/ml fibroblast
growth factor (bFGF) and 20 ng/ml epidermal growth fac-
tor (EGF) (Promega, Madison, Winsconsin).
Differentiation of mouse ES-NS and CNS-NSC
To assess differentiation, multicellular aggregates were dis-
sociated by incubation with Accutase (Innovative Cell
Technologies, Inc., San Diego, CA) at 37°C for 10 minutes.
Single cell suspensions were plated onto poly-ornithine
(Sigma-Aldrich, St. Louis, MO)/mouse laminin (Invitrogen
Corp, Carlsbad, CA) coated plates (BD FalconTM, BD
Biosciences, San Jose, CA) in NB27 medium without
growth factors and cultured for 7 days.
Co-culture with muscularis externa-myenteric plexus
Adult C57BL/6 J and TgN(GFPU)5Nagy mice (3-5 week
old males, Jackson laboratories) were used. The TgN
(GFPU)5Nagy mice have the Enhanced Green Fluorescent
Protein (EGFP) driven by chicken beta-actin promoter and
CMV intermediate early enhancer which drives GFP
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by cervical dislocation. The small intestine was dissected in
pieces of 1 cm length and placed over a glass rod. A small
incision was made and muscle layers with the adherent my-
enteric plexus were peeled off using cotton swab. The ma-
jority of preparations contained only longitudinal muscle
and myenteric plexus and therefore we referred to them as
LM-MP. LM-MPs were cultured at 37°C in 5% CO2 for
24 hrs in DMEM containing 10% FBS and 100U/ml
penicillin-streptomycin (all reagents from Invitrogen
Corp.). ES-NS were dissociated and plated onto poly-
ornithine/laminin coated plates at a density of 2000 cells
cm-2 in NB27 medium supplemented with 1000 U/ml LIF,
10 ng/ml FGF2 and 50 ng/ml EGF. Cells were cultured for
18 hrs before placing the LM-MPs into a 0.4 μm micro-
porous insert (Corning Inc., Corning, NY, USA) inside
each well (5 pieces per 24 mm-diameter insert). Co-
cultured ES-NS were maintained in NB27 medium with-
out growth factors and cultured for 10 days. Freshly pre-
pared LM-MPs were placed in the inserts after 5 days.
Control ES-NS were cultured in the same conditions with-
out LM-MPs.
Flow cytometry analysis
Cells were dissociated using Accutase digestion according
to manufacturer’s instructions (Innovative Cell Technolo-
gies, Inc., San Diego, CA) and collected by centrifugation.
5 x 105 – 1 x 106 cells were fixed in ice-cold 4% parafor-
maldehyde for 15 minutes at room temperature (RT).
Cells were then blocked and permeabilized for 5 minutes
in PBS containing 0.1% Triton X-100 and 2% normal goat
serum (NGS). Incubation with Ki67 antibody diluted in
PBS containing 2% NGS was carried out for 30 minutes
at RT, followed by incubation with secondary antibody
for another 30 minutes (see Table 1 for a list of antibodies
used). Cells were resuspended in 500 μl of PBS contain-
ing 2% NGS and processed with the analytical Flow Cyt-
ometer FACSCanto (Becton-Dickinson, Franklin Lakes,
NJ USA).
Real time PCR analysis
Total RNA was extracted from cells using the TRIzol kit
(Invitrogen Corp.) according to manufacturer’s instruc-
tions. First-strand cDNA was then generated using Taq-
Man Reverse Transcription Regents (Applied Biosystems,
Foster City, CA, USA). Quantitative real-time polymerase
chain reaction (PCR) was carried out in multiplex using
the PTC 200 Peltier Thermal Cycler equipped with
Chromo 4 Continuous Fluorescence Detector (MJ Re-
search Waltham, MA, USA). PCR was performed using
GeneAmp PCR kit and AmpliTaq Gold polymerase (Ap-
plied Biosystems) with the following cycling conditions: 2
minutes at 50°C, 10 minutes at 95°C, followed by 40
cycles of 15 seconds at 95°C, 1 minute at 60°C andfluorescence plate reading. The following sequence-
specific primers and probes were designed using Primer
Express software 2.0 (Applied Biosystems): β-III tubulin:
Fw GGTCTGGCGCCTTTGGA, Rv AGTTGTTGC
CAGCACCACTCT, probe Cy5-CCTATTCAGGCCCGA
CAACTTTATCTTTGGT-IBRQ; PGP9.5: Fw GCTTCG
CCGACGTGCTA, Rv TTGCTTTTTCCTGAAGTTTT
CATG, probe Cy5-CTGCTGCTCCTGTTTCCCCTC
ACG-IBRQ; peripherin: Fw GCATCTCAGTGCCGGTT
CAT, Rv TGGGACTCTGTCACCACCTTCT, probe
TexRed-TTGCCTCTCTAAGTTTAAAGACGACTG-





CAGCGGCCCTGA-TAMRA; α smooth muscle actin:
Fw GAGACTCTCTTCCAGCCATCTTTC, Rv TGAT
GCTGTTATAGGTGGTTTCGT, probe 6FAM-ATGCC
CGCTGACTCCATCCCAA-TAMRA. Ribosomial RNA
18 s (primers and VIC-conjugated probe from Applied
Biosystems) was measured as a reference gene. Cycle
Threshold (CT) values were quantified using Opticon
Monitor 2 software (MJ research) and normalized calcu-
lating the mRNA level of each probe (x) relative to the
amount of 18 s mRNA (reference gene) as follow: mRNA
(x) = 2 CT (18 s) – CT (x) x 100. Mouse brain cDNA was
used as positive control for all primers and probes and
NO-RT reactions were used as negative control to check
for genomic DNA contaminations.
Western blot analysis
Cells were dissociated and collected in pellets, which,
after incubation overnight at -80°C, were lysed in ice-
cold buffer containing 2% sodium dodecyl sulphate
(SDS), protease cocktail inhibitor (Sigma-Aldrich),
1 mM phenylmethylsulphonylfluoride (PMSF), 1 mM
dithiothreitol (DTT), 5 mM ethylenediaminetetraacetic
acid (EDTA) in 50 mM Tris-HCl, pH 7.4. After centrifu-
gation, the supernatants were collected and protein con-
tent was determined (BSA Protein Assay Kit; Pierce).
Protein samples were processed for SDS-polyacrylamide
gel electrophoresis (PAGE) with Mini-Protean Gel-3 sys-
tem (Bio-Rad laboratories, Hercules, CA, USA). After
electrophoresis, proteins were transferred to Polyvinyli-
dene Difluoride (PVDF) membranes (Bio-Rad). Blots
were incubated in blocking buffer (5% non-fat dry milk in
TBS containing 0.1% Tween 20; TBST) for 1 hr at RT and
probed with primary antibodies (Table 1A) overnight at 4°
C and horseradish peroxidase (HRP)-conjugated second-
ary antibodies (Table 1B) for 1 h at RT. Detection was per-
formed using ECL plus kit (Amersham) and exposure of
X-ray films (Bioexpress) then developed with M35A-X-
OMAT Processor (Kodak, Rochester, NY, USA). Band
Table 1 List of primary (A) and secondary (B) antibodies used for Immunofluorescence (IF), Flow Cytometry (FC) and
Western blot (WB) analysis
A.
Primary Ab Host Dilution Specificity Source
Ki67 Rabbit 1:100 FC Proliferating cells Abcam
Nestin Mouse 1:2000 WB, IF Neural progenitor cells BD
βIII-Tubulin Mouse 1:2000 IF; 1:5000 WB Neurons Promega
Chicken 1:2000 IF Neurons Aves Laboratories
PGP 9.5 Rabbit 1:2000 WB, IF Neurons Chemicon
Peripherin Rabbit 1:2000 WB, IF Neurons Chemicon
MAP-2 Chicken 1:2000 WB, IF Neurons Aves Laboratories
nNOS Mouse 1:2500 WB Neurons BD
Rabbit 1:200 IF Neurons Zymed
GFAP Rabbit 1:2000 IF 1:5000 WB Glial cells DAKO
α-SMA Rabbit 1:1000 IF 1:5000 WB Smooth muscle cells Abcam
GAPDH Mouse 1:10000 WB Loading control Abcam
B.
Secondary Ab Host Dilution Source
Alexa 633 anti rabbit Goat 1:200 FC Molecular Probes
Alexa 594 anti mouse or rabbit Goat 1:200 IF Molecular Probes
Alexa 488 anti mouse or rabbit Goat 1:200 IF Molecular Probes
HRP conjugated anti mouse or Rabbit Goat 1:20000 WB Zymed
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ard, Meriden, CT, USA) and data were normalized to the
expression of the housekeeping protein GAPDH.
Immunofluorescence analysis
Cells were fixed in ice-cold 4% paraformaldehyde for 15
minutes at RT, blocked and permeabilized for 1 hr with
PBS containing 0.3% Triton X-100 and 5% NGS. Sam-
ples were incubated with primary antibodies (Table 1A)
diluted in PBS containing 5% NGS overnight at 4°C and
with secondary antibodies (Table 1B) for 1 hour at RT.
Sections and slides were cover-slipped with mounting
media containing the nuclear stain DAPI (Vector La-
boratories, Burlingame, CA). LM-MP preparations were
processed similarly with the following modifications: in-
cubation in Pronase (Biomedia) for 5 minutes at RT after
fixation, primary and secondary antibody incubation for
72 hrs and 1.5 hrs respectively at RT in PBS containing
1.5% NGS, 0.3% Triton-X100 and 0.01% Na Azide. Sam-
ples were examined with an Olympus BX60 microscope
(Olympus, Melville, NY, USA) equipped with fluores-
cence and digital imaging with a cooled CCD camera
(Photometrics CoolSNAP, Roper Scientific, Duluth, GA,
USA) and Metaview software (Universal Imaging Corp.,
West Chester, PA, USA).
Cell counts were performed by counting the number
of immunopositive cells for a given antibody andexpressing the results as number of positive cells versus
total cells number (determined using the nuclear coun-
terstain DAPI that forms fluorescent complexes with
natural double-stranded DNA and it is used to label the
nuclei in all the cells). An independent investigator who
was blinded to the treatment counted three regions per
slides. A total of 3 experiments were counted.
Intra-pyloric transplantation
To enable the detection of the cells in vivo, dissociated ES-
NS cells were labeled with CM-DiI (Molecular Probes,
Eugene, OR) according to manufacturer’s instructions.
After washing in PBS, the cells were resuspended at a con-
centration of 50,000 cells/μl in PBS containing 500 μM
caspase-1 inhibitor (Ac-YVAD-CMK, Calbiochem, La Jolla,
CA, USA) and kept on ice. Adult male C57BL/6 J mice
(Jackson laboratories) were anesthetized with 0.4 ml of 6%
ketamine/4% xylazine intraperitoneally. A midabdominal
incision was made and the pylorus identified. Two microli-
ters of ES-NS suspension were injected bilaterally into the
mid-pylorus immediately subserosal using a 22-gauge nee-
dle attached to a 10 μl Hamilton syringe.
One week following ES-NS transplantation, mice were
deeply anesthetized with sodium pentobarbital (70 mg/kg
intraperitoneally), transcardially perfused, and fixed with
freshly prepared ice-cold 4% paraformaldehyde in 0.1 M
PBS (pH 7.4). The pylorus was removed, post-fixed in 4%
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sucrose solution in PBS overnight at 4°C. Tissues were rap-
idly frozen in O.C.T. embedding medium (Tissue Tek;
Sakura, Tokyo, Japan) over dry ice–chilled isopentane
(Sigma Chemical Co, St Louis, MO). Frozen serial sections
(16 μm thick) were cut on a cryostat (TBS, Durham, NC),
placed on Superfrost Plus slides (VWR, West Chester, PA),
and stored at -20°C until needed.
Statistical analysis
RT-PCR and WB data were expressed as mean ± SEM.
For comparisons between the groups One Sample T Test
was used. Statistical significance was assumed if
P< 0.05.
Results
Characterization of murine ES cells
Characterization of the 129/Ola ES cell line was carried out
by investigating common attributes of embryonic stem
cells: colony morphology and alkaline phosphatase expres-
sion. Murine ES cells grown in feeder-free conditions
formed colonies with the typical round and compacted
morphology (Figure 1A) and with a high expression of alka-
line phosphatase, a marker expressed by embryonic stem
cells but not by their differentiated derivatives (Figure 1B)
[27].
Induction of neural progenitors from ES cells
In order to start with an enriched population of neural pre-
cursors we have modified existing protocols for generating
ES-derived neurospheres [14,15]. ES cells were grown for
7 days into non-coated tissue culture flasks in Neurobasal
medium supplemented with the neurotrophic serum-free
supplement B27 and the growth factors FGF-2, EGF and
LIF. Under these conditions ES cells grow as floating multi-
cellular aggregates, which morphologically resemble the
neurospheres that are formed by neural stem cells (NSC)
isolated from fetal and adult brain (Figure 1C). ES cells
show expression of the neural stem cell marker nestin sug-
gesting spontaneous neural differentiation under the cul-
ture conditions used (data not shown). This is not unusual
and has been previously reported by other investigators
[28]. However, the expression of nestin was limited to few
ES cells (data not shown) and was significantly increased
after neural induction in ES-derived neurospheres (ES-NS)
(Figure 1D), with a 2.3 fold increase in protein expression
compared to undifferentiated ES cells cultures (P< 0.01,
n=3; Figure 1E).
Some cells within the neurospheres also express the
neural crest stem cell marker p75 and the neural pro-
genitor marker βIII-tubulin. On the other hand, the ma-
ture neuronal marker PGP9.5 and the glial marker
GFAP were not detectable in ES-NS (Figure 1F-I and
Figure 1J).To further explore the neurogenic potential of ES-NS,
neuronal differentiation of ES-NS was assayed after
1 week of culture in the absence of any growth factor
and compared to that of uncommitted ES cells. Under
these conditions ES-NS were able to generate neurons
identified by a clear uni/bi-polar neuronal morphology
(Figure 2A-B) and by the expression of the neuronal
marker βIII-tubulin (1.8 fold increase as compared to ES
cells; P< 0.01, n = 3. Figure 2C). Moreover, when we
compared differentiated ES-NS to cells differentiated
from CNS-derived neurospheres (CNS-NS), we found
that the expression level of βIII-tubulin measured by
Western blot analysis was similar between the two
groups (Figure 2D).
Interestingly, ES-NS did not generate astrocyte-like cells
as indicated by the lack of expression of glial fibrillary acidic
protein (GFAP), a marker of the glial lineage, as assessed by
both Western blotting and RT-PCR (data not shown).
Small intestinal longitudinal muscle-myenteric plexus
preparations
To investigate the effects of putative gut factors on the
differentiation of ES-NS we established an in vitro co-
culture protocol. The procedure involves the organotypic
culture of strips of longitudinal muscle and the adherent
myenteric plexus (LM-MP) derived from the small intes-
tine of adult mice. LM-MP tissues were placed into the
inside compartment of transwells separated from the
ES-NS by a microporous membrane (0.45 μm pore size)
that allows the exchange of soluble factors but not of
cells. The maximum length of time for co-culture was
defined as the approximate time needed for cells to
reach confluency (10 days). To prove the effectiveness of
this system we performed preliminary experiments in
which LM-MP preparations were obtained from TgN
(GFPU)5Nagy mice. No GFP positive cells were found in
the compartment containing the ES-NS cells after
10 days of co-culture (data not shown), proving that only
soluble molecules are exchanged between the two sides
of the membrane. LM-MP preparations were also tested
by immunoreactivity for βIII-tubulin, GFAP and α-
smooth muscle actin (α-SMA) during the co-culturing
period, which showed integrity of both the neural plexus
and smooth muscle for at least 5 days (Figure 3) and
attested to their viability. Therefore, in the co-culture
experiments, LM-MP strips were changed with fresh
preparations at day 5 of the culturing period, in order to
avoid tissue degeneration.
Neurogenic potentials of ES-NS in co-culture with LM-MP
When co-cultured with mouse LM-MP, ES-NS showed a
significant increase in the mRNA expression of the neur-
onal markers βIII-tubulin, PGP 9.5 and peripherin as well
as of neuronal nitric oxide synthase, nNOS, as compared
Figure 1 Characterization of 129/Ola murine ES cells and of ES-derived neurospheres. (A) Phase contrast image of ES cell colonies with the
characteristic compact morphology. (B) ES cells colonies show a high expression of the stem cell marker alkaline phosphatase. Calibration
bars = 25 μm. (C) Phase contrast micrograph of ES-derived neurospheres (ES-NS) after 7 days in culture in serum-free medium supplemented with
growth factors (NB27 +GF) and (D) immunofluorescence analysis showing the expression of the neural stem cell markers nestin (red). Nuclei are
counterstained with DAPI (blue). Calibration bars = 25 μm. (E) Western blot analysis of nestin expression in ES-NS compared to ES cells grown
under regular conditions. n = 3 ** P< 0.01 One Sample T test. (F-I) Immunofluorescence analysis of ES-NS showing the expression of the neural
crest stem cell marker p75 (red); of the neuronal progenitor marker βIII-tubulin (red); and the lack of expression of the neuronal marker PGP9.5
(green) and of the glial marker GFAP (red). Nuclei are stained with DAPI and are shown in blue. Calibration bars = 25 μm. (J) Western blot analysis
of ES-NS.
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and 1.7 fold increases respectively, P< 0.05, n = 7;
Figure 4A). This was accompanied by a corresponding in-
crease in protein expression as shown by Western blot
analysis (2.4 fold for βIII-tubulin, 1.8 for PGP 9.5, 1.5 forperipherin and 2.3 for nNOS, P< 0.05, n =6. Figure 4B).
The expression of ChAT was not detected in differentiated
ES-NS (data not shown). Interestingly, ES-NS did not gen-
erate astrocyte-like cells as indicated by the lack of GFAP
expression, both at the mRNA and protein level.
Figure 2 Neurogenic potential of ES-derived neurospheres. ES
cells (A) and ES-NS (B) were plated out onto poly-ornithine/laminin-
coated plates and allowed to differentiate by culturing them in NB27
medium without growth factors for 7 days. More βIII-tubulin-positive
cells (in red) are visible in ES-NS cultures as compared to ES cells
differentiated under the same conditions. Nuclei are counterstained with
DAPI (blue). Calibration bars =25 μm. (C) Western blot analysis for
βIII-tubulin expression in differentiated ES-NS compared to differentiated
ES cells. n=3, **P< 0.01 One Sample T test. (D) Western blot analysis for
βIII-tubulin expression in differentiated ES-NS and CNS-NS. n=3 for
ES-NS and n=4 for CNS-NSC, P=0.83, Student’sT-test.
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ings, revealing a significant increase of percentages of cells
positive for βIII-tubulin, PGP9.5 and nNOS after exposure
to LM-MP compared to control cultures (βIII-tubulin
42.3± 7.0% vs 23.6±6.3%, PGP9.5 39.9± 6.6% vs
21.6± 4.7%, nNOS 15.8± 3.5% vs 11.8±4.6%, with 3.2, 2.3
and 1.6 fold increases respectively, P< 0.05, n=3.
Figure 4C-D). Moreover, neurons showed a more devel-
oped morphology after co-culture with LM-MP than in
control cultures as highlighted by immunoreactivity for
cytoskeleton proteins such as peripherin (Figure 5A-B) and
βIII-tubulin (Figure 5C-D). It has to be noted that in the
control group, the number of cells expressing peripherin in
relation to the total number of cells in the culture was rela-
tively low (as confirmed by the low signal in the WBanalysis shown in Figure 4B). However, the cells that did
express peripherin were highly positive by immunofluores-
cence analysis thus explaining the images that we are
showing in Figure 5.
We also demonstrated that increased cell proliferation
is unlikely to account for elevated levels of neuronal
markers since the percentage of Ki67 expressing cells is
similar in the co-culture and control groups (6.1 ± 1.2%
and 5.6 ± 1.2% respectively, P = 0.81, n = 3; Figure 5E).
Immunofluorescence analysis also revealed the appear-
ance of a small percentage of cells (less than 1% of the
total) positive for smooth muscle marker α-SMA in the
co-cultured ES-NS (Fig 6A-B). By Western blot analysis
we could detect α-SMA only after co-culture with LM-
MP (Fig 6D). This is most likely due to the signal being
below the detection limit due to the low number of cells
positive for this marker in the control culture. However,
RT-PCR confirmed a 2.7 fold increase of SMA expres-
sion in the co-cultured group as compared with control
(P< 0.01, n = 6; Figure 6C).
Intrapyloric transplantation of ES-derived neurospheres
To assess preliminary feasibility of ES-derived neuro-
spheres transplantation, we used the experimental proto-
col of intrapyloric transplantation previously described
for CNS-derived neural stem cells (CNS-NS) [6–9]. ES-
NS were grafted in the pyloric muscle layer of adult male
mice; survival and differentiation were assessed 1 week
after transplantation. At the time point chosen grafted
cells were found mainly in the muscle and the submuco-
sal layers showing good survival (Figure 7A). On the
other hand, immunohistochemistry failed to reveal ex-
pression of the neuronal markers βIII-tubulin, periph-
erin, MAP-2 and nNOS as well as the non-neuronal
markers GFAP and α-smooth muscle actin by the
engrafted ES-NS (Figure 7 B-D).
Discussion
Although ES cells can differentiate into neural precur-
sors in the absence of any external influence, only a
small percentage of neural cells survive and differentiate
under these conditions [29,30]. In this report we have
therefore developed a modified protocol to enrich our
culture in ES-derived neural progenitors. Using this ap-
proach we obtained multi-cellular aggregates that share
many properties with neurospheres generated from
CNS-derived neural stem cells, namely, sphere morph-
ology, nestin expression and the ability to produce neu-
rons. Moreover, ES-NS express p75, a marker found in
neural crest-derived stem cells [31]. Having established a
neuronally biased ES population, we next examined the
effects of an enteric neuromuscular environment on its
further differentiation. It has been shown that co-culture
of progenitor cells with mature cells or tissues can drive
Figure 3 Time course analysis of small intestine longitudinal muscle – myenteric plexus (LM-MP) preparations. Immunoreactivity for the
neuronal marker βIII-tubulin (red, A-B) and for the glial marker GFAP (red, C-D) reveal a preserved anatomy of the myenteric plexus and its
ganglia (insets) in mouse small intestine LM-MP strips maintained in culture in NB27 medium for 5 days (B, D) compared to fresh preparations
(A, C). Similarly, the persisting reactivity for α-smooth muscle actin, α-SMA (red, E-F) shows the longitudinal muscle still intact after
5 days in culture (F, fresh preparation control in E). Nuclei are counterstained with DAPI (blue). Calibration bars = 50 μm.
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We therefore established a controlled in vitro system
where ES-NS are co-cultured with strips of small intestine
longitudinal muscle and the adherent myenteric plexus
(LM-MP). Although the presence of the myenteric plexus
in the LM-MP preparation might suppress ES-NS differ-
entiation, our results show that intestinal LM-MP exert a
considerable neurogenic effect on ES-NS, as evidenced by
the enhanced expression of several neuronal markers, in-
cluding peripherin, the intermediate filament which is a
well established marker of peripheral neurons [34] and the
enzyme neuronal nitric oxide synthase (nNOS), respon-
sible for the production of the critical enteric neurotrans-
mitter, nitric oxide [35]. On the other hand, ChAT was not
expressed in ES-NS under either co-culture or control
conditions. Although our data does not provide an explan-
ation for the lack of ChAT expression, it is interesting to
note that nNOS-expressing neurons appear early during
ENS development while ChAT-expressing neurons areonly detected at later embryonic stages and post-natally
[36–38].
The neurogenic effect observed after co-culture of ES-
NS with LM-MP could be attributed to either increased
proliferation and/or improved differentiation of neural
progenitors within ES-NS. Our data show that the num-
ber of neurons (PGP9.5 and nNOS positive) is increased
after co-culture with LM-MP, but not the number of
proliferating cells (Ki67 positive). Moreover, co-culture
with LM-MP clearly affects the morphology of neurons
produced, which possess longer axons and form a more
extensive and organized network as compared to con-
trols. This suggests that soluble factors released from
the LM-MP promote survival and differentiation of
neural progenitors but not their proliferation. Therefore
the main effect in our ES-NS co-culturing protocol is to
favor differentiation of neurons.
In addition to inducing neuronal differentiation, we
also observed a minor myogenic effect of LM-MP on
Figure 4 Co-culture of ES-NS with LM-MP preparations for 10 days leads to a significant increase in neuronal differentiation. Expression
of neuronal and glial markers was assessed by RT-PCR (A), Western Blot (B) and immunohistochemistry (C). The pan neuronal markers βIII-tubulin
and PGP9.5 and peripherin, as well as the neuronal subtype marker nNOS were increased both at the mRNA and protein levels in the LM-MP
co-cultured group as compared to control (fold change ranging from 1.3 to 3.2). The glial marker GFAP was not detected at this stage of
differentiation by any of the analysis performed. (A) Changes of mRNA level in ES-NS co-cultured with LM-MP as compared to control cultures
(ES-NS without LM-MP). n = 7. * P< 0.05, ** P< 0.01. (B) Changes in protein level in ES-NS co-cultured with LM-MP as compared to control
cultures. n = 6. * P< 0.05, ** P< 0.01. (C) Changes in percentage of positive cells in ES-NS co-cultured with LM-MP as compared to control
cultures. n = 3. * P< 0.05, ** P< 0.01. (D-E) Representative images of immunoreactivity for PGP9.5 (green), a marker for mature neurons, in control
cultures and ES-NS co-cultured with LM-MP. PGP9.5 immunoreactivity extends to the neurites (arrows, E) although it is less intense partly due to
the difference in focal planes. Scale bar = 25 μm. (F-G) Representative images of immunoreactivity for nNOS (red) in control cultures and ES-NS
co-cultured with LM-MP showing increased proportion of nNOS+ cells after co-culture with LM-MP compared to controls. Scale bar = 50 μm.
Nuclei are counterstained with DAPI (blue).
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NS can be induced to express smooth muscle markers
in vitro [39], on the other hand, neural crest cells
(NCC), which give rise to enteric neurons and glia dur-
ing development, are also able to generate smooth
muscle cells in different embryonic compartments [40].
Therefore our findings could be due to an in vitro
artifact or to a NCC-like potential of ES-NS.
ES-NS failed to express the glial marker GFAP under
any of our culture conditions, unlike other studies using
ES-derived neural precursors, which have reported the
capability of these progenitors to differentiate into both
the neuronal and glial lineage in vitro [11,14]. The discrep-
ancy between these reports and our results may be due to
differences in culture conditions used to produce ES-NS.
Alternatively, the fact that neural progenitors have a stage-dependent potential giving rise first to neurons and then
to glia during neural commitment [41], may suggest that
prolonged culture periods are necessary to generate glial
cells. Therefore differentiation of ES-NS for longer periods
of time (more than 10 days) and analysis of a more wide-
spread panel of glial markers will need to be performed.
It is well known that the environment plays a key role
on the differentiation of ES cells into defined pheno-
types. We have developed a robust and informative
in vitro system where soluble factors released by gut tis-
sues are able to drive neuronal differentiation of ES-
derivatives appropriate for the ENS lineage. The nature
of these signals has yet to be determined, but may in-
clude well-known soluble factors of the gut such as
GDNF, NO, TGFβ (respectively produced by glial, neur-
onal and muscle cells) or other molecules. Further
Figure 5 Differentiated neurons in LM-MP treated ES-NS exhibit a more complex and mature morphology than control neurons.
Morphology of neurons is shown by immunoreactivity for the neuronal markers peripherin (red, A-B) and βIII-tubulin (red, C-D) in ES-NS co-
cultured with LM-MP (B, D) or control (A, C). Neurons arising from ES-NS exposed to LM-MP show pronounced processes and form a network-
like structure, whereas control neurons show either absence of neuritogenesis (A) or shorter blunt processes (C) white arrowheads. Nuclei are
counterstained with DAPI (blue). Calibration bars = 25 μm. (E) Analysis of the expression of the cell cycle marker Ki67 by flow cytometry does not
reveal any significant change between the two groups. n = 3, P = 0.81, Student’s T-test.
Figure 6 Smooth-muscle actin expression in ES-NS. α- SMA immunoreactivity (red) in ES-NS cultured in the presence (A) or absence (B) of
LM-MP. A small percentage of α-SMA positive cells were generated from LM-MP treated ES-NS as compared to the control group where they
were rare. Nuclei are counterstained with DAPI (blue). Calibration bar = 25 μm. (C) RT-PCR analysis confirmed the increase of α-SMA transcript in
LM-MP treated ES-NS as compared to control (n = 6, ** P< 0.01). This result was corroborated by Western Blot analysis shown in panel D (40 μg
of total protein extract per lane. Loading control GAPDH, Glyceraldehyde 3-phosphate dehydrogenase), indicating increased expression of α-SMA
in the LM-MP co-culture group as compared to control where the expression of α-SMA was negligible.
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Figure 7 Intrapyloric transplantation of ES-NS. (A) Grafted DiI-labeled ES-NS (red) after 7 days from transplantation were found mainly in the
muscle and submucosal layers. (B-D) Immunofluorescence staining revealed a failure by the grafted ES-NS to express mature phenotype markers
such as peripherin (green, B), GFAP (green, C) and α-smooth muscle actin (green, D). Nuclear staining with DAPI (blue). M, muscle; SM,
submucosa; Mu, mucosa. Calibration bars = 25 μm.
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identify these factors.
Although transplantation of ES-NS in the pyloric muscle
layer of wild type mice showed adequate survival of grafted
cells at 1 week, no markers of terminal differentiation were
noted. This contrasts with many reports that showed suc-
cessful transplantation of ES-derived neural precursors in
the CNS [13–15]. This may be due to the presence of in-
hibitory factors, either secreted or contact-based that were
not captured in vitro using isolated LM-MP co-cultures.
This difference also probably reflects the vastly more com-
plex environment of the gut wall, consisting of a mixture of
epithelium, neurons, glia, interstitial cells of Cajal and
smooth muscle, along with resident and circulation-derived
immunocytes. These cellular elements may provide con-
flicting cues to ES cells, resulting in inhibition or retard-
ation of their differentiation. Further, non-neural factors
such as neo-angiogenesis may be required for the optimal
differentiation of these cells.
We have previously shown that CNS-derived NS
grafted in the pylorus of mice generate neurons and glia
and partially restore gastric function [7]. We here show
that ES-derived neurospheres do not compare to CNS-
NS after transplantation. Clearly, there is a lot more to
be done in order to fully understand the mechanisms
for this different behavior. It is possible that the lack of
GFAP expression (and glia?) accounts for the poor out-
come in vivo. Further work will need to be done to ad-
dress this question.
In this regard, our study had several limitations. First, it
should be noted that the time frame of these experiments
was relatively short. Long-term survival and differentiationof grafted cells needs to be investigated in further studies to
fully assess the potential of ES-NS to form enteric neurons
in vivo. It is also possible that “priming” of the ES, perhaps
by exposure to LM-MP prior to the transplantation may re-
sult in a better outcome. Finally, the inability to precisely
localize the injection into the muscle layer may be a factor
in preventing the appropriate signals from reaching the ES
cells (in our study most of them were found in the sub-
mucosa). Therefore, this study cannot confidently exclude
the therapeutic potential of ES cell for repopulating the
ENS. On the other hand, if they truly do not differentiate,
they may retain the ability to proliferate (which we did not
examine), which is of concern because of the risk of
tumorigenesis.Conclusions
A variety of cell sources are currently being explored for
use in cell transplantation studies including CNS-
derived NS, neural crest stem cells (NCCS), enteric
neural progenitor cells (ENPC) and embryonic stem cells
(ES) [5,42]. Among these sources, ES cells have the ad-
vantage of being available in large numbers and of being
capable to adopt a full spectrum of cell fates. In this
study we have shown that ES-derived neurospheres (ES-
NS) are able to generate specific phenotypes under the
influence of diffusible factors in vitro, while they fail to
differentiate after transplantation in the gut. The inabil-
ity of ES-NS to adopt a neuronal phenotype in vivo
might be due to local inhibitory influences that prevents
their differentiation, and suggests that ES-NS may not
be suitable candidates for ENS regeneration.
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